3D Systems $DDD promised 3D-printed lungs. Then the stock dropped nearly 50%. In this episode of Sue Wall Street: Holding Wall Street Accountable, Cassie and Bill break down a wild securities class action involving futuristic biotech, shifting revenue milestones, and massive shareholder losses. Perfect for retail investors, finance buffs, and anyone watching the intersection of innovation and accountability. Expect sharp commentary, real case facts, and a splash of humor.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.